RMD Add to watchlist $238.53 +4.42 (+1.89%) Last updated: Nov 12, 2026 04:06
52-Week Range
$238.53
$180.27 $238.53 $277.67

Fundamentals Overview

ResMed Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 20.7 PEG 1.72 P/B 5.23 P/S 5.74

Profitability

ROE 25.14% Net margin 27.8%

Risk (Beta)

0.76 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 57% confidence Risk: Lower Volatility — Beta 0.76. Diversify and only invest what you can afford to lose.

Pressures (Sell):

PEG 1.72

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$32.93B
P/E (TTM)
20.67
EPS (TTM)
N/A
Dividend Yield
1.25%
52-Week Range
$180.27 - $277.67
Volume vs Avg
0.71x
71% of avg (Below)
Beta
0.76

About

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest fr...
Sector: Healthcare
Headquarters: US
Beta: 0.76 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) 20.67
PEG (TTM) 1.72
P/B (TTM) 5.23
P/S (TTM) 5.74
Profitability
ROE (TTM) 25.14%
ROA (TTM) 18.49%
Revenue growth (YoY) N/A
Net margin (TTM) 27.79%
Gross margin (TTM) 61.22%
Operating margin (TTM) 34.1%
Debt to equity (TTM) 0.07

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for RMD.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.